Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

519 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Advantages of the standardized use of preoperative fascia iliaca block versus conventional analgesia in older adults with fragility hip fracture: A retrospective cohort study at two hospitals in Colombia.
Libos Zabala A, Tihanyi Feldman J, Bernate JD, Ricaurte L, Morales DC, Patiño AF, Pesantez RF, Salavarrieta JE, Sanint V, López AM, Olarte CM. Libos Zabala A, et al. Among authors: lopez am. Sci Prog. 2025 Jan-Mar;108(1):368504241305904. doi: 10.1177/00368504241305904. Sci Prog. 2025. PMID: 39763176 Free PMC article.
Best practices for secondhand smoke and secondhand aerosol protection and evidence supporting the expansion of smoke- and aerosol-free environments: Recommendations from the 2nd Joint Action on Tobacco Control.
Possenti I, Gallus S, Lugo A, López AM, Carreras G, Fernández-Megina R, González-Marrón A, Gorini G, Koprivnikar H, Papachristou E, Lambrou A, Schoretsaniti S, Pénzes M, Carnicer-Pont D, Fernandez E. Possenti I, et al. Among authors: lopez am. Tob Prev Cessat. 2024 Oct 21;10. doi: 10.18332/tpc/193147. eCollection 2024. Tob Prev Cessat. 2024. PMID: 39434811 Free PMC article. No abstract available.
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
Fong Y, Dang L, Zhang B, Fintzi J, Chen S, Wang J, Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Yu C, Magaret CA, Molitor C, Borate B, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Mu J, Makowski M, Makhene MK, Nayak SU, Roberts PC, Follmann D, Gilbert PB; Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team. Fong Y, et al. Clin Infect Dis. 2024 Sep 26:ciae465. doi: 10.1093/cid/ciae465. Online ahead of print. Clin Infect Dis. 2024. PMID: 39325506
519 results